MENU
URGN
AS OF
Dec 24 closing price
Price
$23.76
Change
+$0.36 (+1.54%)
Capitalization
1.11B
76 days until earnings call
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
URGN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

UroGen Pharma (URGN) Ownership - Who owns UroGen Pharma?

UroGen Pharma Ltd is a clinical-stage biotechnology firm specializing in solutions for urothelial and specialty cancers... Show more

Industry: #Biotechnology
#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Biotechnology
Address
400 Alexander Park Drive
Phone
+1 646 768-9780
Employees
201
Web
https://www.urogen.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.11B
P/E Ratio
N/A
Total Cash
127.03M
Projected Growth
N/A
Total Debt
128.35M
Revenue
96.52M
Risk (Beta)
2.65
Dividend Yield
N/A
Total Cash/Share
2.71
Total Debt/Equity
N/A
Revenue/Share
2.03 USD as % of share price

Fundamentals

URGN
Capitalization
1.11B
P/E Ratio
N/A
Risk (Beta)
2.65
Dividend Yield
N/A
Total Cash
127M
Total Cash/Share
2.71
Total Debt
128M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
2.03%
Revenue
96.5M
ROE
N/A
Book Value
-115.41M
P/B Ratio
16.23
Cash Flow
N/A
Earnings
-3.47
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
128K
Current Ratio
3.99
Current Revenue Per Employee
108624.51
Dividends Per Share - Security
N/A
EBITDA
-144.14M
Float
N/A
Float - Current
N/A
Gross Income Margin
88.07
Revenue To Assets
-67.62
Shares Held By Institutions
1.04B
Shares Outstanding - Current
46.8M
Total Liabilities
300M
Total Volume MTD
N/A
Value
N/A
Gain YTD
123.099
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
URGN
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. URGN showed earnings on November 06, 2025. You can read more about the earnings report here.
View AI-Driven Trading for URGN
A.I. Advisor
published General Information

General Information

a developer of therapies for urological pathologies

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
400 Alexander Park Drive
Phone
+1 646 768-9780
Employees
201
Web
https://www.urogen.com